Gail V W Johnson

Title: Gail V W Johnson: Innovator in Cancer Treatment

Introduction

Gail V W Johnson is a notable inventor based in Rochester, NY (US). She has made significant contributions to the field of cancer treatment through her innovative research and development of pharmaceutical compounds. Her work focuses on the prevention and treatment of cancer, showcasing her dedication to improving healthcare outcomes.

Latest Patents

Gail V W Johnson holds 1 patent for her invention titled "TG2 inhibitor piperazine compounds and uses thereof." This patent provides Tissue Transglutaminase (TG2) inhibitor compounds, along with compositions and methods for their use in preventing or treating cancer. The compounds of Formula I, along with their pharmaceutically acceptable salts, represent a significant advancement in cancer therapy.

Career Highlights

Throughout her career, Gail has worked with esteemed institutions such as the University of Ottawa and the University System of Maryland. Her experience in these academic environments has allowed her to collaborate with leading researchers and contribute to groundbreaking studies in her field.

Collaborations

Gail has collaborated with notable colleagues, including Jeffrey W Keillor and Abdullah Akbar. These partnerships have enriched her research and expanded the impact of her work in cancer treatment.

Conclusion

Gail V W Johnson's innovative contributions to cancer treatment through her patent and collaborations highlight her commitment to advancing medical science. Her work continues to inspire future research and development in the field.